Study of HS-10382 Combination in Patients With Chronic Myeloid Leukemia (CML)
Study of HS-10382 Combination in Patients With Chronic Myeloid Leukemia (CML)
Not yet recruiting · NCT06530810 · Registry updated 2024-07-31Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of HS-10382 Combination in Patients With Chronic Myeloid Leukemia (CML) | Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase, Myeloproliferative Disorders, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bone marrow disorder, hematologic disorder, leukemia, leukemia, myeloid, accelerated-phase, myeloid leukemia, neoplasm | Not yet recruiting | Phase 1 | 2024-07-31 | NCT06530810 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Jiangsu Hansoh Pharmaceutical Co., Ltd. | 59 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||